Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

  1. Castañón, E.
  2. Rolfo, C.
  3. Viñal, D.
  4. López, I.
  5. Fusco, J.P.
  6. Santisteban, M.
  7. Martin, P.
  8. Zubiri, L.
  9. Echeveste, J.I.
  10. Gil-Bazo, I.
Revista:
Journal of Translational Medicine

ISSN: 1479-5876

Ano de publicación: 2015

Volume: 13

Número: 1

Tipo: Artigo

DOI: 10.1186/S12967-015-0622-X GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus